Hypoxia Abrogates Tumor-Suppressive Activities of C/EBPδ in Pancreatic Cancer
Leonie Hartl1,2, Marieke S Ten Brink3, Hella L Aberson1,2
1Center for Experimental and Molecular Medicine, Laboratory for Experimental Oncology and Radiobiology, Amsterdam UMC Location University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.
Abstract:
Pancreatic ductal adenocarcinoma (PDAC) is a dismal disease with a low 5-year survival rate of only 13%. Despite intense research efforts, PDAC remains insufficiently understood. In part, this is attributed to opposing effects of key players being unraveled, including the stroma but also molecules that act in a context-dependent manner. One such molecule is the transcription factor C/EBPδ, where we recently showed that C/EBPδ exerts tumor-suppressive effects in PDAC cells in vitro. To better understand the role of C/EBPδ in different contexts and the development of PDAC, we here build on these findings and assess the effect of C/EBPδ in a PDAC model in mice. We establish that the lack of oxygen in vivo-hypoxia-counteracts the tumor-suppressive effects of C/EBPδ, and identify a reciprocal feedback loop between C/EBPδ and HIF-1α. RNA sequencing of C/EBPδ-induced cells under hypoxia also suggests that the growth-limiting effects of C/EBPδ decrease with oxygen tension. Consequently, in vitro proliferation assays reveal that the tumor-suppressive activities of C/EBPδ are abrogated due to hypoxia. This study demonstrates the importance of considering major physiological parameters in preclinical approaches.
Insights
Hypoxia counteracts the tumor-suppressive effects of C/EBPδ in pancreatic cancer. This study reveals a feedback loop with HIF-1α, highlighting the importance of oxygen levels in preclinical models.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Pancreatic ductal adenocarcinoma (PDAC) has a poor prognosis, with a 5-year survival rate of 13%.
- The role of key molecules in PDAC development is context-dependent, complicating research.
- Transcription factor C/EBPδ exhibits tumor-suppressive effects in vitro in PDAC cells.
Purpose of the Study:
- To investigate the role of C/EBPδ in a mouse model of PDAC.
- To understand how physiological conditions, specifically hypoxia, affect C/EBPδ function in PDAC.
- To elucidate the interaction between C/EBPδ and hypoxia-inducible factor 1-alpha (HIF-1α).
Main Methods:
- In vivo assessment of C/EBPδ in a mouse PDAC model.
- RNA sequencing of C/EBPδ-induced cells under hypoxic conditions.
- In vitro proliferation assays to evaluate C/EBPδ activity under varying oxygen tensions.
Main Results:
- Hypoxia in vivo counteracts the tumor-suppressive effects of C/EBPδ.
- A reciprocal feedback loop between C/EBPδ and HIF-1α was identified.
- The growth-limiting effects of C/EBPδ diminish with decreasing oxygen levels, abrogating its tumor-suppressive activity in vitro.
Conclusions:
- Physiological parameters like hypoxia significantly influence the function of tumor-associated molecules in PDAC.
- Preclinical models must account for in vivo conditions, such as oxygen tension, for accurate results.
- Understanding context-dependent molecular roles is crucial for developing effective PDAC therapies.
Related Concept Videos
Cell Specific Gene Expression
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Abnormal Proliferation
Regulation of Angiogenesis and Blood Supply
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


